Memory Problems Linked to Slower Rate of Decline in Alzheimer’s

June is Alzheimer’s and Brain Awareness Month. Research from Cleveland Clinic has found that initial memory problems are linked with a slower rate of decline in Alzheimer’s disease and dementia.

Translate to Spanish or other 102 languages!

Research from Cleveland Clinic has found that initial memory problems are linked with a slower rate of decline in Alzheimer’s disease and dementia. Image for illustration purposes
Research from Cleveland Clinic has found that initial memory problems are linked with a slower rate of decline in Alzheimer’s disease and dementia. Image for illustration purposes

Mega Doctor News

- Advertisement -

CLEVELAND CLINIC – June is Alzheimer’s and Brain Awareness Month.

Research from Cleveland Clinic has found that initial memory problems are linked with a slower rate of decline in Alzheimer’s disease and dementia.

“What we found out was that people with early memory symptoms alone compared to people with early language problems or visual-spatial problems, they tend to have a slightly slower disease progression in terms of their functional abilities,” explained Jagan Pillai, MD, neurologist for Cleveland Clinic and lead author on the study.

- Advertisement -

Dr. Pillai said those with language problems, spatial ability and judgment issues seemed to be affected more over a period of time – specifically in their daily functional abilities.

He said it seems to make sense since a person with just memory difficulties could find other ways to compensate, like keeping track of what they’re doing by recording themselves or writing down notes. That would then allow them to remain functional.

He also noted that memory difficulties come from another part of the brain than language problems, for example. So, how the disease progresses could be different.

“The portion of the brain that is first impacted by the disease tends to determine the symptoms that goes along with the disease and also the kind of progression from there to other regions,” said Dr. Pillai.

- Advertisement -

Dr. Pillai said having this information available can better help physicians diagnose people and prepare them for the future.

It can also be useful for researchers when it comes to testing different medications to treat Alzheimer’s disease.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Op Ed: Turn awareness into action: Why breast cancer screening matters

Mega Doctor News By Lorena Saenz Gonzalez Breast cancer affects the lives of millions of women and...

STHS and Prominence Health Team Up on Medication Safety

 The Senior Living Seminar offered practical tips on managing prescriptions, avoiding harmful drug interactions and improving overall health outcomes.

Texas Oncology to Host Breast Cancer Awareness Symposium in McAllen on Oct. 16th

The Breast Cancer Awareness Symposium 2026 is an educational and networking event hosted by Texas Oncology and sponsored by Caris Life Sciences, bringing together oncology specialists, surgeons, advanced practice providers, and community healthcare professionals to discuss the latest advances in breast cancer prevention, diagnosis, treatment, survivorship, and reconstruction. The symposium's theme, "Breast Cancer 2026: Early Detection, Modern Care, and Survivorship Through Community Partnership," highlights the importance of multidisciplinary collaboration and patient-centered care

FDA Approves First Heart Valve Designed to Grow with Children

The U.S. Food and Drug Administration today approved the Autus Size-Adjustable Valve, a surgically implanted pulmonary heart valve for pediatric patients with congenital pulmonary valve disease.
- Advertisement -